Children's Medical Research Institute

Formed in 2006, AdiStem Ltd. is an international biotechnology company which discovers and develops novel methods and apparatus to assist clinicians in using autologous blood (platelet rich plasma) and adult adipose-derived stem cells to address serious disease conditions, and to assist in particular cosmetic and plastic surgery procedures.
AdiStem owns proprietary technologies for stem cell isolation and administration that are shared with qualified medical practitioners through instructional courses, workshops and seminars. Due to its clinician and hospital relationships and collaborative efforts with medical institutions, AdiStem is now a leading provider of autologous adipose-derived adult stem cell products and procedures.

In 2010 Adistem established a research and development base in Melbourne Australia to exploit discoveries connected with its stem cell research. Adistem Pty Ltd is utilising modern drug discovery techniques to connect the clinical benefits observed in autologous adipose-derived adult stem cell treatments to active biomolecules which are produced by the body in response to the stem cell treatments. Specifically Adistem Pty Ltd is developing several peptide therapeutics against a number of chronic disease targets.

Healthy Animals. Let's Make It Happen, Together.

At Argenta we've been dedicated to animal health from day one. Since 2006, we've been a trusted partner to clients who need our expertise, partnership and no-challenge-too-tough attitude to bringing innovative new animal health products to market.

Because we are the only global CRO and CMO specializing in animal health, we are uniquely able to offer clients of all sizes a comprehensive product development solution from Molecule to Market, at any scale.

The day-to-day ethos that drives our company forward is a mission focused on global partnerships, a Molecule to Market approach, and of course, innovation.

At the core of our business and our organisation is collaboration — among our global team and with our customers. Working together, we continually challenge ourselves and each other to continue to innovate to develop the best animal health technologies and products possible.

From animal scientists to veterinarians to engineers and other industry experts, our 450+ strong global team is a passionate and diverse group united in their commitment to healthy animals.

We operate from Research & Development locations in New Zealand and the US and (EMA and FDA) GMP approved Manufacturing sites in New Zealand, the United Kingdom (Scotland) and the United States (Fort Dodge, Iowa).

Our company was founded in New Zealand by Doug Cleverly, a scientist who naturally felt more at home in the lab solving problems than in the boardroom. Doug imbued the company with the spirit of Kiwi ingenuity and a global perspective. He saw a need in the market for an animal health company that could provide the highest quality services to customers of all sizes, all over the world. To this day, we are still dedicated to animal health and our founder's legacy of problem solving and inventiveness lives on within the organisation.

Let’s get in touch!

Datapharm is Australia’s original independent full-service Contract Research Organisation (CRO), est. 1987, providing clinical trial management, design, site set-up, monitoring, statistical services, data management (including eCRFs), medical writing, pharmacovigilance and auditing.
Datapharm has earned an enviable reputation for quality, following involvement in hundreds of clinical trials in over 35 therapeutic areas, Phases I (including first-in-human) to IV, for Big Pharma, Biotech, Medical Device companies and Non-profit organisations.
Datapharm works to ICH GCP and international regulatory authority standards with an overlay of excellent project management to achieve project milestones.
Datapharm offers services internationally through the global CRO consortium DAI-SYS.

Our four clinical research sites are capable of performing studies from small scale Phase 1b trials to large scale, longer term Phase 3 studies. Since 2001 we have been trusted to perform over 120 clinical studies on behalf of worldwide pharmaceutical companies, contract research organisations and individual researchers. As a result we have accumulated a large volunteer database for our clinical trials.

Advanced Molecular Technologies Pty Ltd (AMT) is a contract research organisation (CRO) established in 2005, specialising in medicinal chemistry and custom organic synthesis. The provided services involve the synthesis of target molecules, the manufacturing (larger-scale) of chemical materials, analytical chemistry, chemical method development and optimisation, drug discovery and synthetic organic research.

AMT is also a manufacturer and supplier of chemicals in Victoria, Australia, distributing specialty products to partners, institutions and companies worldwide.

AMT has extensive experience in organoboron, organosilicon, PEG-linkers and fluorophore technology, with many of these discrete molecules available for purchase on their website. More recently, AMT is spinning-out its own initiatives through novel technology developed within the pharmaceutical and veterinary industries.

Equipped with a 400 MHz NMR machine, HPLC, GC, FT-IR and several other analytical pieces of equipment, AMT also readily provides analytical services to the chemical industry.